Notice of Intent to Sole Source Invetech GMP Korus SUS Kits
Closed Pre-Solicitation Posted
- Solicitation number
- 25-001317
- Agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health (NIH) Clinical Center, Office of Purchasing and Contracts intends to award a fixed-price purchase order to Invetech Inc. to supply 80 units of GMP Korus Single-Use System (SUS) Kits. These kits are necessary to support the patient care activities of the Department of Transfusion Medicine, Center for Cellular Engineering, which manufactures human cells and tissue-based products for use in clinical protocols. Invetech Inc. is the sole source capable of providing the GMP Korus SUS Kits that are compatible with the Invetech Korus Counterflow Elutriation System used by the department. This acquisition will be conducted under the simplified acquisition procedures of FAR Part 13, which allow for sole-source awards when only one source is reasonably available.
This pre-solicitation notice does not involve any set-aside designations. Invetech Inc. is the current and sole known provider of the required GMP Korus SUS Kits. The total value of the anticipated fixed-price purchase order is not stated. Interested parties capable of providing similar products are invited to submit capability statements by the due date of November 14, 2024, but the government retains sole discretion in determining whether to conduct a competitive procurement.
Notice text
Notice of Intent to Sole Source Invetech GMP Korus SUS Kits
NAICS Code: 325413-In Vitro Diagnostic Substance Manufacturing (1250 Average Number of Employees|
Product Service Code: 6550-In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
Place of Performance: Bethesda, MD 200892
POTS: 25-001317
Description:
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institutes of Health, Clinical Center, Office of Purchasing and Contracts on behalf of the Department of Transfusion Medicine, Center Cellular Engineering intends to award a fixed price purchase order to Invetech Inc. located at 9980 Huennekens Street, Suite 140, in San Diego, CA 92121-2968 on a firm fixed price sole source award to supply GMP SUS Kits.
Product Description:
Line Item 0001
Product Number: Description Unit of Measure Quantity
A005913-02-A GMP Korus SUS Kits Each 80
The Department of Transfusion Medicine, Center Cellular Engineering is responsible for the manufacture of human cells and tissue-based products utilized in phase I and phase II clinical protocols for transplantation, adoptive immunotherapy and gene therapy. The cell processing procedures are tailored to each of the 50 or more different patient-care clinical research protocols. The Department of Transfusion Medicine, Center Cellular Engineering has a need for GMP Korus SUS Kits in support of patient care. Invetech Inc. is the only known source capable of supplying the GMP Korus SUS Kits that are compatible with the Invetech Korus™ Counterflow Elutriation System. The GMP SUS Kits are not interchangeable with other manufacture’s instruments and the only kits that are compatible with the Invetech Korus™ Counterflow Elutriation System. Intech Inc. Is the only known source that can provide the proprietary GMPS SUS Kits.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1). For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Interested Parties
Interested parties capable of providing the same or similar products or services described in this notice may submit a capability statement outlining their capability to perform the described work. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. The determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.
Comments to this announcement, referencing this posting number on the email subject line, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Sheri Eiri Contract Specialist via email to sheri.eiri@nih.gov by the due date November 14, 2024 by Noon 12:00 pm EST and time marked in this notice.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity